insights_auto
Hvorfor har ANW gått opp? 51,28%?
Gå mer i dybdenchevron_right
ANW:FRA
Immuron Ltd
0,030 €
arrow_upward
+51,28%(+0,010) 1 D
12. okt., 08:05:52 GMT+2 · EUR
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for ANW …
Åpne
0,03 €
Høy
0,03 €
Lav
0,03 €
Markedsverdi
9,82 mill.
Snittvolum
627,00
Volum
8,30k
52 u høy
0,04 €
52 u lav
0,01 €
Antall ansatte
8
Åpne
0,03 €
Høy
0,03 €
Lav
0,03 €
Markedsverdi
9,82 mill.
Snittvolum
627,00
Volum
8,30k
52 u høy
0,04 €
52 u lav
0,01 €
Antall ansatte
8
Nyhetssaker
Fra nettkilder og nyhetspartnere
https://www.dars.gov.et/
·
for 1 uke siden
Immuron (IMRN) Slips 1.83% to $1.07 as Shares Drift Toward Lower Support - MA Cross Alert
Profil
Immuron is a biotechnology company based in Melbourne, Australia. In 2008, the company changed its name to Immuron Limited, having previously operated as Anadis Limited.
Immuron is focused on antigen-primed and dairy-derived health products. Its proprietary technologies allow for rapid development of polyclonal antibody and other proteins-based solutions for a range of diseases. The company specialises in nutraceutical, pharmaceutical and therapeutic technology products for conditions such as oral and GI mucositis, avian influenza, E. coli travellers' diarrhoea and Anthrax containment.
In 2005, Anadis signed an agreement with Quebec's Baralex Inc. and Valeo Pharma Inc. for the distribution of Travelan, a product made by Anadis for the Canadian market. Wikipedia
Om Immuron Ltd
Administrerende direktør-
Ansatte8
Grunnlagt1994
HovedkontorBlackburn North, Victoria, Australia
Sektor-
Nettstedimmuron.com.au